MedPath

Celecoxib in the treatment of depressio

Not Applicable
Conditions
Major depressive disorder.
Major Depressive episode
Registration Number
IRCT201405271556N58
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
50
Inclusion Criteria

1-Diagnosis of breast cancer from more than 100 days ago, 2-receiving chemotherapy, 3-score lower than 20 in Hamilton Rating Scale for depression 4-Mild to moderate major depressive disorder based on DSM-V 5- age between 18 to 60 years old, 6-copmplain of pain
Exclusion criteria: 1-receiving antidepressants during the last month, 2-receiving ECT during the last two months, 3-history of cardiovascular disease, 4-pregnant and nursing women, 5-Thyroid disease, 6-Psychotic disorder, 7-other psychiatric disorders

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of depression. Timepoint: Baseline and weeks 1-3-6 after beginig of treatment. Method of measurement: by Hamiltion Depression Rating Scale 17-Item.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath